Literature DB >> 33906918

Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.

Jia Liu1,2, Xuecheng Yang3,2, Hua Wang3, Ziwei Li3,2, Hui Deng3,2, Jing Liu3,2, Shue Xiong3,2, Junyi He3,2, Xuemei Feng3,2, Chunxia Guo3, Weixian Wang3, Gennadiy Zelinskyy4,2, Mirko Trilling4,2, Kathrin Sutter4,2, Tina Senff5, Christopher Menne5, Joerg Timm5, Yanfang Zhang6, Fei Deng6, Yinping Lu3,2, Jun Wu3,2, Mengji Lu4,2, Dongliang Yang3,2, Ulf Dittmer4,2, Baoju Wang1,2, Xin Zheng3,2.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected over 120 million people and killed over 2.7 million individuals by March 2021. While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remain to be analyzed. Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19-convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2-unexposed individuals (UI). Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI. Concomitant with the decrease in NKT-like cells, an increase in the percentage of annexin V and 7-aminoactinomycin D (7-AAD) double-positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery. Significant increases in regulatory T cell frequencies and TIM-3 expression on CD4 and CD8 T cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by granzyme B (GzmB) expression, was significantly diminished. However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully able to proliferate and produce effector cytokines upon T cell receptor (TCR) stimulation. Collectively, we provide a comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.IMPORTANCE Wuhan was the very first city hit by SARS-CoV-2. Accordingly, the patients who experienced the longest phase of convalescence following COVID-19 reside here. This enabled us to investigate the "immunological scar" left by SARS-CoV-2 on cellular immunity after recovery from the disease. In this study, we characterized the long-term impact of SARS-CoV-2 infection on the immune system and provide a comprehensive picture of cellular immunity of a convalescent COVID-19 patient cohort with the longest recovery time. We revealed that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease; in particular, a profound NKT cell impairment was found in the convalescent phase of COVID-19.
Copyright © 2021 Liu et al.

Entities:  

Keywords:  COVID-19; NKT cell; SARS-CoV-2; cellular immunity

Year:  2021        PMID: 33906918     DOI: 10.1128/mBio.00085-21

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  12 in total

1.  Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.

Authors:  Feargal J Ryan; Christopher M Hope; Makutiro G Masavuli; Miriam A Lynn; Simon C Barry; Branka Grubor-Bauk; David J Lynn; Zelalem A Mekonnen; Arthur Eng Lip Yeow; Pablo Garcia-Valtanen; Zahraa Al-Delfi; Jason Gummow; Catherine Ferguson; Stephanie O'Connor; Benjamin A J Reddi; Pravin Hissaria; David Shaw; Chuan Kok-Lim; Jonathan M Gleadle; Michael R Beard
Journal:  BMC Med       Date:  2022-01-14       Impact factor: 8.775

Review 2.  Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.

Authors:  Carlos A Labarrere; Ghassan S Kassab
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

3.  Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2.

Authors:  Gehan Ahmed Mostafa; Hanan Mohamed Ibrahim; Abeer Al Sayed Shehab; Yasmin Gamal El Gendy; Dina Medhat Mohamed Aly; Ghada Abdel Haleem Shousha
Journal:  Eur J Pediatr       Date:  2022-03-02       Impact factor: 3.860

4.  Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection.

Authors:  Jingzhi Yang; Teding Chang; Liangsheng Tang; Hai Deng; Deng Chen; Jialiu Luo; Han Wu; TingXuan Tang; Cong Zhang; Zhenwen Li; Liming Dong; Xiang-Ping Yang; Zhao-Hui Tang
Journal:  Front Immunol       Date:  2022-02-16       Impact factor: 7.561

5.  Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.

Authors:  Bárbara Torres Rives; Yaíma Zúñiga Rosales; Minerva Mataran Valdés; Hilda Roblejo Balbuena; Goitybell Martínez Téllez; Jacqueline Rodríguez Pérez; Lilia Caridad Marín Padrón; Cira Rodríguez Pelier; Francisco Sotomayor Lugo; Anet Valdés Zayas; Tania Carmenate Portilla; Belinda Sánchez Ramírez; Luis Carlos Silva Aycaguer; José Angel Portal Miranda; Beatriz Marcheco Teruel
Journal:  Immunobiology       Date:  2022-04-12       Impact factor: 3.152

Review 6.  Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients.

Authors:  Mohammad A Al-Mterin; Alhasan Alsalman; Eyad Elkord
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

7.  Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.

Authors:  Zhaoli Liu; Gizem Kilic; Wenchao Li; Ozlem Bulut; Manoj Kumar Gupta; Bowen Zhang; Cancan Qi; He Peng; Hsin-Chieh Tsay; Chai Fen Soon; Yonatan Ayalew Mekonnen; Anaísa Valido Ferreira; Caspar I van der Made; Bram van Cranenbroek; Hans J P M Koenen; Elles Simonetti; Dimitri Diavatopoulos; Marien I de Jonge; Lisa Müller; Heiner Schaal; Philipp N Ostermann; Markus Cornberg; Britta Eiz-Vesper; Frank van de Veerdonk; Reinout van Crevel; Leo A B Joosten; Jorge Domínguez-Andrés; Cheng-Jian Xu; Mihai G Netea; Yang Li
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 8.  The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.

Authors:  Esther Moga; Elionor Lynton-Pons; Pere Domingo
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

9.  Neutrophil and Eosinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease.

Authors:  B N Jukema; K Smit; M T E Hopman; C C W G Bongers; T C Pelgrim; M H Rijk; T N Platteel; R P Venekamp; D L M Zwart; F H Rutten; L Koenderman
Journal:  Front Allergy       Date:  2022-07-27

10.  Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.

Authors:  Sean Wei Xiang Ong; Siew-Wai Fong; Barnaby Edward Young; Yi-Hao Chan; Bernett Lee; Siti Naqiah Amrun; Rhonda Sin-Ling Chee; Nicholas Kim-Wah Yeo; Paul Tambyah; Surinder Pada; Seow Yen Tan; Ying Ding; Laurent Renia; Yee-Sin Leo; Lisa F P Ng; David Chien Lye
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.